IOBTQ
IO Biotech, Inc.Former ticker of IO Biotech, Inc. · IOBT stock page →
$0.00010000 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.00010000
1 year
−100.0%
from $0.9089 · Oct 27
30 days
0.0%
from $0.00010000
52-week range
$0.00010000–1.04
−100% from high · low Aug 4
Avg volume 20D
6.6K
Oct 1 spike 38.5K
Short interest
🔒 Subscribers only
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- A Jan 26 Piper Sandler downgrades
- R Jun 8 Nasdaq has filed a Form 25-NSE to remove IO Biotech's common stock f…
Signal stack
Where each data set points today.
- InstitutionsBEARISH
Q1 2026: 1 added (0 new), 5 trimmed or exited.
- TrendRANGE
43% below its 50-day average. New closing low $0.00010000 on Oct 23.
Who's buying
13F· Q1 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| MARSHALL WACE, LLP | TRIM | $18.1K |
| MORGAN STANLEY | TRIM | $12.1K |
| MILLENNIUM MANAGEMENT LLC | ADD | $11.4K |
| CITIGROUP INC | TRIM | $4.3K |
| Beacon Pointe Advisors, LLC | NEAR_EXIT | $2.5K |
| UBS Group AG | TRIM | $1.8K |
| MARSHALL WACE, LLP | TRIM | $261.9K |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $126.4K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Jan 2026Recent actions
| Date | Firm | Rating |
|---|---|---|
| Jan 26, 2026 | Piper Sandler DOWNGRADE | Neutral |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 8, 2026 SEC
Nasdaq has filed a Form 25-NSE to remove IO Biotech's common stock from listing, effective June 18, 2026, following a…
25-NSE — Impact 9/10
Mar 31, 2026 Inst.
MARSHALL WACE, LLP — TRIM
301,291 shares ($18.1K)
Mar 31, 2026 Inst.
MORGAN STANLEY — TRIM
206,215 shares ($12.1K)
SecBot reports
1 filing · 0 bullish · 1 bearishAll IOBTQ filing & press-release reports (1)
- 25-NSE reportJun 8, 2026